BODY-MASS, PREDIAGNOSTIC WEIGHT-LOSS AND PECULIARITIES OF LIPIDEMIA IN WOMEN-ONCOLOGICAL PATIENTS - THE ROLE OF TUMOR-LOCALIZATION

Women with endometrial, breast, rectal, colon or stomach cancer were e xamined 3-7 days before surgical treatment. It was shown that tumor lo calization and body weight loss in the nearest months (years) prior ma lignancy manifestation modify the pattern of lipidemia and its depende nce upon anthropometric status, in particular, body mass excess. This fact must be taken into account while choosing approaches for lipids m etabolism correction in oncological patients.